The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Hepatic Veins

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Hepatic Veins


High impact information on Hepatic Veins

  • After 3 hours, the specific activity of uridine in the hepatic vein was more than three times that in the arterial circulation [6].
  • Therefore, we investigated SGU in six patients with NIDDM and six weight-matched control subjects by means of the hepatic vein catheterization (HVC) technique [7].
  • We validated this method in 12 nondiabetic subjects using hepatic vein catheterization (HVC) during an oral glucose tolerance test [8].
  • L-(1-13C,15N)leucine, L-(ring-2H5)phenylalanine, and L-(ring-2H2) tyrosine were infused intravenously, and isotopic enrichments of [1-13C,15N]-leucine, (13C)leucine, (13C)ketoisocaproate, (2H5)phenylalanine, [2H4]tyrosine, (2H2)tyrosine, and 13CO2 were measured in arterial, hepatic vein, and femoral vein samples [9].
  • When the perfusate contained 200 mM thiourea, the comparable recovery of [14C]urea from the hepatic veins exceeded that of 3HOH by a factor of 3.48 +/- 0.44 (n = 7) [10].

Chemical compound and disease context of Hepatic Veins


Biological context of Hepatic Veins


Anatomical context of Hepatic Veins


Associations of Hepatic Veins with chemical compounds

  • Splanchnic exchange of glucose and gluconeogenic precursors was measured using the hepatic vein catheter technique [25].
  • Evidence that supports that assumption was obtained by comparing the randomization of 14C in the urinary glucuronide with that in glucose in blood from the hepatic vein of four of the subjects before and after they were given glucagon [26].
  • MAIN OUTCOME MEASURES: Radiotracer-derived measures of norepinephrine release to plasma, central hemodynamics, wedge hepatic vein pressure, and measures of renal function [27].
  • The HVI-CHP system was used to determine directly the doxorubicin plasma concentration in the hepatic vein and the hepatic venous flow rate, and simultaneously, to eliminate hepatic re-entry of the drug [28].
  • Propranolol has been reported to reduce portal and wedged hepatic vein pressures in man and may be useful for the prevention of variceal bleeding [29].

Gene context of Hepatic Veins


Analytical, diagnostic and therapeutic context of Hepatic Veins


  1. Membranous obstruction of the inferior vena cava associated with a myeloproliferative disorder: a clue to membrane formation? Sevenet, F., Deramond, H., Hadengue, A., Casadevall, N., Delamarre, J., Capron, J.P. Gastroenterology (1989) [Pubmed]
  2. Diagnosis of Budd-Chiari syndrome by pulsed Doppler ultrasound. Bolondi, L., Gaiani, S., Li Bassi, S., Zironi, G., Bonino, F., Brunetto, M., Barbara, L. Gastroenterology (1991) [Pubmed]
  3. Marked hepatic congestion caused by a thoracoabdominal aneurysm. Sigal, E., Pogany, A., Goldman, I.S. Gastroenterology (1984) [Pubmed]
  4. Transformation of inferior vena caval thrombosis to membranous obstruction in a patient with the lupus anticoagulant. Terabayashi, H., Okuda, K., Nomura, F., Ohnishi, K., Wong, P. Gastroenterology (1986) [Pubmed]
  5. Hepatic venous outflow block caused by short-length hepatic vein stenoses. Valla, D., Hadengue, A., el Younsi, M., Azar, N., Zeitoun, G., Boudet, M.J., Molas, G., Belghiti, J., Erlinger, S., Hay, J.M., Benhamou, J.P. Hepatology (1997) [Pubmed]
  6. Novel single-pass exchange of circulating uridine in rat liver. Gasser, T., Moyer, J.D., Handschumacher, R.E. Science (1981) [Pubmed]
  7. Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus. Ludvik, B., Nolan, J.J., Roberts, A., Baloga, J., Joyce, M., Bell, J.M., Olefsky, J.M. J. Clin. Invest. (1997) [Pubmed]
  8. A noninvasive method to measure splanchnic glucose uptake after oral glucose administration. Ludvik, B., Nolan, J.J., Roberts, A., Baloga, J., Joyce, M., Bell, J.M., Olefsky, J.M. J. Clin. Invest. (1995) [Pubmed]
  9. Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients. Nair, K.S., Ford, G.C., Ekberg, K., Fernqvist-Forbes, E., Wahren, J. J. Clin. Invest. (1995) [Pubmed]
  10. Reversible inhibition of urea exchange in rat hepatocytes. Effros, R.M., Jacobs, E., Hacker, A., Ozker, K., Murphy, C. J. Clin. Invest. (1993) [Pubmed]
  11. Hemodynamic study during transdermal application of nitroglycerin tape in patients with cirrhosis. Iwao, T., Toyonaga, A., Sumino, M., Takagi, K., Ohkubo, K., Inoue, R., Tanikawa, K. Hepatology (1991) [Pubmed]
  12. Collagenisation of the Disse space in alcoholic liver disease. Orrego, H., Medline, A., Blendis, L.M., Rankin, J.G., Kreaden, D.A. Gut (1979) [Pubmed]
  13. Splanchnic and systemic hemodynamics in early abstinence and after ethanol administration in non-cirrhotic alcoholic patients. Silva, G., Fluxá, F., Bresky, G., Backhouse, C., Palma, M., Ruiz, M., Hirsch, S., Iturriaga, H. J. Hepatol. (1994) [Pubmed]
  14. Effect of vasopressin and somatostatin on hemodynamics and blood gases in patients with liver cirrhosis. Naeije, R., Hallemans, R., Mols, P., Mélot, C., Reding, P. Crit. Care Med. (1982) [Pubmed]
  15. Ursodeoxycholic acid reduces increased circulating endothelin 2 in primary biliary cirrhosis. Dimoulios, P., Kolios, G., Notas, G., Matrella, E., Xidakis, C., Koulentaki, M., Tsagarakis, N., Kouroumalis, A., Kouroumalis, E. Aliment. Pharmacol. Ther. (2005) [Pubmed]
  16. Release of prostanoids into the portal and hepatic vein in patients with chronic liver disease. Wernze, H., Tittor, W., Goerig, M. Hepatology (1986) [Pubmed]
  17. Renal sodium retention in cirrhosis: tubular site and relation to hepatic dysfunction. Wood, L.J., Massie, D., McLean, A.J., Dudley, F.J. Hepatology (1988) [Pubmed]
  18. The effects of ethanol administration on portal pressure and gastroesophageal collateral blood flow in patients with alcoholic cirrhosis. Ready, J.B., Hossack, K.F., Rector, W.G. Hepatology (1990) [Pubmed]
  19. Hepatorenal syndrome. Studies of the effect of vascular volume and intraperitoneal pressure on renal and hepatic function. Cade, R., Wagemaker, H., Vogel, S., Mars, D., Hood-Lewis, D., Privette, M., Peterson, J., Schlein, E., Hawkins, R., Raulerson, D. Am. J. Med. (1987) [Pubmed]
  20. Effect of clonidine on liver oxygen extraction during alcohol withdrawal in man. Hadengue, A., Moreau, R., Lebrec, D., Gaudin, C., Rueff, B., Benhamou, J.P. J. Hepatol. (1994) [Pubmed]
  21. Hepatic extraction and renal production of 3,3'-diiodothyronine and 3',5'-diiodothyronine in man. Faber, J., Faber, O.K., Lund, B., Kirkegaard, C., Wahren, J. J. Clin. Invest. (1980) [Pubmed]
  22. Hepatic venous blood and the development of pulmonary arteriovenous malformations in congenital heart disease. Srivastava, D., Preminger, T., Lock, J.E., Mandell, V., Keane, J.F., Mayer, J.E., Kozakewich, H., Spevak, P.J. Circulation (1995) [Pubmed]
  23. Evidence that interaction of hepatocytes with the collecting (hepatic) veins triggers position-specific transcription of the glutamine synthetase and ornithine aminotransferase genes in the mouse liver. Kuo, F.C., Darnell, J.E. Mol. Cell. Biol. (1991) [Pubmed]
  24. The effects of intra-arterial and intraportal injections of vasopressin on the simultaneously perfused hepatic arterial and portal venous vascular beds of the dog. Richardson, P.D., Withrington, P.G. Circ. Res. (1978) [Pubmed]
  25. Influence of a 60-hour fast on insulin-mediated splanchnic and peripheral glucose metabolism in humans. Björkman, O., Eriksson, L.S. J. Clin. Invest. (1985) [Pubmed]
  26. Quantitation of the pathways of hepatic glycogen formation on ingesting a glucose load. Magnusson, I., Chandramouli, V., Schumann, W.C., Kumaran, K., Wahren, J., Landau, B.R. J. Clin. Invest. (1987) [Pubmed]
  27. Increased sympathetic nervous activity and the effects of its inhibition with clonidine in alcoholic cirrhosis. Esler, M., Dudley, F., Jennings, G., Debinski, H., Lambert, G., Jones, P., Crotty, B., Colman, J., Willett, I. Ann. Intern. Med. (1992) [Pubmed]
  28. Regional pharmacokinetics of doxorubicin following hepatic arterial and portal venous administration: evaluation with hepatic venous isolation and charcoal hemoperfusion. Iwasaki, T., Ku, Y., Kusunoki, N., Tominaga, M., Fukumoto, T., Muramatsu, S., Kuroda, Y. Cancer Res. (1998) [Pubmed]
  29. Effect of propranolol on hepatic and systemic hemodynamics in dogs with chronic bile duct ligation. Willems, B., Villeneuve, J.P., Huet, P.M. Hepatology (1986) [Pubmed]
  30. Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1alpha in alcoholic liver disease. Fisher, N.C., Neil, D.A., Williams, A., Adams, D.H. Gut (1999) [Pubmed]
  31. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. Brismar, K., Fernqvist-Forbes, E., Wahren, J., Hall, K. J. Clin. Endocrinol. Metab. (1994) [Pubmed]
  32. Effect of cold-ischemia time on C-X-C chemokine expression and neutrophil accumulation in the graft liver after orthotopic liver transplantation in rats. Kataoka, M., Shimizu, H., Mitsuhashi, N., Ohtsuka, M., Wakabayashi, Y., Ito, H., Kimura, F., Nakagawa, K., Yoshidome, H., Shimizu, Y., Miyazaki, M. Transplantation (2002) [Pubmed]
  33. Immunological reactions in liver graft perireperfusion in living donor liver transplantation--change of expression of adhesion molecules, deposition of immunoglobulins and cytokine level. Ohkohchi, N., Hirano, T., Satake, M., Satomi, S. Hepatogastroenterology (2003) [Pubmed]
  34. Levels of interleukin (IL)-6, IL-8, and IL-1 receptor antagonist in the hepatic vein following liver surgery. Ueda, T., Sakabe, T., Oka, M., Maeda, Y., Nishida, M., Murakami, F., Maekawa, T. Hepatogastroenterology (2000) [Pubmed]
  35. Obstruction of inferior vena caval orifice by giant left atrium in patients with mitral stenosis. A Doppler echocardiographic study from the right parasternal approach. Minagoe, S., Yoshikawa, J., Yoshida, K., Akasaka, T., Shakudo, M., Maeda, K., Tei, C. Circulation (1992) [Pubmed]
  36. Treatment of the Budd-Chiari syndrome with percutaneous transluminal angioplasty. Case report and review of the literature. Sparano, J., Chang, J., Trasi, S., Bonanno, C. Am. J. Med. (1987) [Pubmed]
  37. Ultrasonically assisted retrohepatic dissection for a liver hanging maneuver. Kokudo, N., Imamura, H., Sano, K., Zhang, K., Hasegawa, K., Sugawara, Y., Makuuchi, M. Ann. Surg. (2005) [Pubmed]
WikiGenes - Universities